Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy.
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopy.
复制标题
由PI3K/MTOR抑制引起的小儿和成人胶质母细胞瘤放射素化导致核磁共振光谱检测到的早期代谢改变。
DOI:
10.18632/oncotarget.18206
复制
发表时间:
2017-07-18
期刊:
影响因子:
--
通讯作者:
Al-Saffar NMS
中科院分区:
文献类型:
--
作者:
Agliano A;Balarajah G;Ciobota DM;Sidhu J;Clarke PA;Jones C;Workman P;Leach MO;Al-Saffar NMS
Poor outcome for patients with glioblastomas is often associated with radioresistance. PI3K/mTOR pathway deregulation has been correlated with radioresistance; therefore, PI3K/mTOR inhibition could render tumors radiosensitive. In this study, we show that NVP-BEZ235, a dual PI3K/mTOR inhibitor, potentiates the effects of irradiation in both adult and pediatric glioblastoma cell lines, resulting in early metabolic changes detected by nuclear magnetic resonance (NMR) spectroscopy. NVP-BEZ235 radiosensitises cells to X ray exposure, inducing cell death through the inhibition of CDC25A and the activation of p21cip1(CDKN1A). Lactate and phosphocholine levels, increased with radiation, are decreased after NVP-BEZ235 and combination treatment, suggesting that inhibiting the PI3K/mTOR pathway reverses radiation induced metabolic changes. Importantly, NVP-BEZ235 potentiates the effects of irradiation in a xenograft model of adult glioblastoma, where we observed a decrease in lactate and phosphocholine levels after seven days of combination treatment. Although tumor size was not affected due to the short length of the treatment, a significant increase in CASP3 mRNA was observed in the combination group. Taken together, our data suggest that NMR metabolites could be used as biomarkers to detect an early response to combination therapy with PI3K/mTOR inhibitors and radiotherapy in adult and pediatric glioblastoma patients.
登录
查看更多内容
影响因子:
5.7
作者:
Beloueche-Babari, M;Jackson, LE;Ronen, SM
通讯作者:
Ronen, SM
影响因子:
2.6
作者:
Hazawa M;Yasuda T;Noshiro K;Saotome-Nakamura A;Fukuzaki T;Michikawa Y;Gotoh T;Tajima K
通讯作者:
Tajima K
DOI:
10.1158/1078-0432.ccr-13-1607
发表时间:
2014-03-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Gil del Alcazar CR;Hardebeck MC;Mukherjee B;Tomimatsu N;Gao X;Yan J;Xie XJ;Bachoo R;Li L;Habib AA;Burma S
通讯作者:
Burma S
影响因子:
64.5
作者:
ELDEIRY, WS;TOKINO, T;VOGELSTEIN, B
通讯作者:
VOGELSTEIN, B
影响因子:
56.9
作者:
Bunz, F;Dutriaux, A;Vogelstein, B
通讯作者:
Vogelstein, B